More information about the 2025 AAAAI / WAO Joint Congress can be accessed here.
Data highlight potential for new diagnostics and therapeutics targeting red meat allergy SOUTH SAN FRANCISCO, Calif., Feb. 10 ...
The focus of the presentation will be on the subgroup of patients who have received 100mg bezuclastinib for at least 48 weeks to highlight the symptomatic benefits of long-term use.
KalVista Pharmaceuticals, Inc. , today announced the presentation of novel data related to long-term prophylaxis and sebetralstat at the Western Society of Allergy, Asthma & Immunology (WSAAI) 2025 ...
Learn the real causes behind uncontrollable coughing and discover effective treatments from medical experts, plus warning ...
Bilateral versus unilateral cases of chronic rhinosinusitis with nasal polyps have notable clinical and laboratory ...
The flames may be out, but the real battle is just beginning. The Los Angeles fires have left a toxic legacy far beyond the ...
Nektar Therapeutics today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for rezpegaldesleukin for the treatment of adult and pediatric patients 12 years ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback